Skip to main content


Figure 3 | Diabetology & Metabolic Syndrome

Figure 3

From: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy

Figure 3

Direct meta-analysis forest plots versus placebo-control. A) HbA1c weighted mean difference, B) weight (kg) weighted mean difference, C) hypoglycaemia odds ratio; CI, confidence interval; DPP-4, dipeptidyl peptidase-4 inhibitors; GLP-1, glucagon-like peptide-1 analogues; N, number of patients; OR, odds ratio; SD, standard deviation; SGLT2, sodium glucose co-transporter 2 inhibitors; WMD, weighted mean difference.

Back to article page